SCHEMBL698375

SCHEMBL698375

COc1c(Cl)cccc1C(C)(O)c1ncc[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.40
ADRA1A P35348 5/20 0.39
ADRA2A P08913 4/20 0.36
ADRA2C P18825 3/20 0.36
ADRA1D P25100 3/20 0.36
ADRA1B P35368 3/20 0.36
TAAR1 Q96RJ0 2/20 0.35
KMT2A Q03164 1/20 0.33
MDM2 Q00987 1/20 0.33
F2RL1 P55085 2/20 0.33
MC4R P32245 1/20 0.32
HPGD P15428 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
RAF1 P04049 1/20 0.31
MAPT P10636 2/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL706070 0.83 CYP19A1 (0.48) CYP19A1ADRA1AADRA2AADRA2CADRA1D
SCHEMBL6299558 0.83 CYP19A1 (0.46) CYP19A1ADRA1AADRA2AADRA2CADRA1D
SCHEMBL698787 0.82 CYP19A1 (0.43) CYP19A1ADRA1AADRA2AADRA2CADRA1D
SCHEMBL27733481 0.78 TAAR1 (0.43) CYP19A1ADRA1AADRA2AADRA2CADRA1D
SCHEMBL704581 0.77 ADRA2A (0.37) CYP19A1ADRA1AADRA2AADRA2CADRA1D
SCHEMBL699180 0.77 CYP19A1 (0.47) CYP19A1ADRA1AADRA2AADRA2CADRA1D
SCHEMBL698443 0.76 CYP19A1 (0.40) CYP19A1ADRA1AADRA2AADRA2CADRA1D
SCHEMBL697855 0.76 CYP19A1 (0.40) CYP19A1ADRA1AADRA2AADRA2CADRA1D
SCHEMBL697435 0.76 CYP19A1 (0.46) CYP19A1ADRA1AADRA2AADRA2CADRA1D
SCHEMBL697775 0.75 TAAR1 (0.44) CYP19A1TAAR1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423199-A1 Substituted imidazoles and their use as pesticides Pfizer Limited (GB) 2012-02-29 EP disclosed
EP-1981853-B1 SUBSTITUTED IMIDAZOLES AND THEIR USE AS PESTICIDES PFIZER LTD (GB) 2011-04-13 EP disclosed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 CYP19A1 1985/4885ADRA1A 498/4885ADRA2A 456/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 CYP19A1 1985/4885ADRA1A 498/4885ADRA2A 456/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 CYP19A1 1985/4885ADRA1A 498/4885ADRA2A 456/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 CYP19A1 1985/4885ADRA1A 498/4885ADRA2A 456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.